Nicotine-Induced cFos Expression in the Hypothalamic Paraventricular Nucleus Is Dependent on Brainstem Effects: Correlations with cFos in Catecholaminergic and Noncatecholaminergic Neurons in the Nucleus Tractus Solitarius

Endocrinology

Volumn 137, Issue 2, 1996, Pages 622-630

  Valentine, James D ^a   Matta, Shannon G ^a,b   Sharp, Burt M ^a,b,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; MECAMYLAMINE; NICOTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN STEM; CATECHOLAMINE NERVE CELL; CATECHOLAMINE SYNTHESIS; CORTICOTROPIN RELEASE; GENE EXPRESSION; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; IMMUNOCYTOCHEMISTRY; LOCUS CERULEUS; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SOLITARY TRACT NUCLEUS;

ANIMALS; BRAIN STEM; CATECHOLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GENES, FOS; IMMUNOHISTOCHEMISTRY; LOCUS COERULEUS; MALE; NEURONS; NICOTINE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, INBRED STRAINS; SOLITARY NUCLEUS;

EID: 0030023156     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.2.8593811     Document Type: Article

References (35)

1. Andersson K, Siegel R, Fuxe K, Eneroth P 1983 Intravenous injections of nicotine induce very rapid and discrete reductions of hypothalamic catecholamine levels associated with increases of ACTH, vasopressin, and prolactin secretion. Acta Physiol Scand 118:35-40
2. Matta SG, Beyer HS, McAllen KM, Sharp BM 1987 Nicotine elevates rat plasma ACTH by a central mechanism. J Pharmacol Exp Therap 243:217-226
3. Matta SG, McAllen KM, Sharp BM 1990 Role of the fourth cerebroventricle in mediating rat plasma ACTH responses to intravenous nicotine. J Pharmacol Exp Therap 252:623-630
4. Andersson K, Eneroth P, Agnati LF 1981 Nicotine-induced increases of noradrenaline turnover in discrete noradrenaline terminal systems of the hypothalamus and median eminence of the rat and their relationship to changes in the secretion of adenohypohyseal hormones. Acta Physiol Scand 113:227-231
5. Fuxe K, Andersson K, Eneroth P, Siegel RA, Agnati LF 1983 Immobilization stress-induced changes in discrete hypothalamic catecholamine levels and turnover, their modulation by nicotine and relationship to neuroendocrine function. Acta Physiol Scand 117: 421-426
6. Matta SG, Singh J, Sharp BM 1990 Catecholamines mediate nicotine-induced adrenocorticotropin secretion via α-adrenergic receptors. Endocrinology 127:1646-1655
7. Matta SG, McCoy JG, Foster CA, Sharp BM 1995 Nicotinic agonists administered into the fourth ventricle stimulate norepinephrine secretion in the hypothalamic paraventricular nucleus: an in vivo microdialysis study. Neuroendocrinology 61:383-392
8. 125]alpha-bungarotoxin binding sites in the nucleus tractus solitarii of the cat. J Comp Neurol 327:194-204
9. Uneo S, Kakehata S, Akaike N 1993 Nicotinic acetylcholine receptors in dissociated rat nucleus tractus solitarii neurons. Neurosci Lett 149:15-18
10. Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J, Swanson L 1989 Distribution of alpha2, alpha3, alpha4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J Comp Neurol 284:314-335
11. Swanson LW, Sawchenko PE, Berol B, Hartman BK, Helle KB, Van Orden DE 1981 An immunohistochemical study of the organization of catecholaminergic cells and terminal fields in the paraventricular and supraopric nuclei of the hypothalamus. J Comp Neurol 196: 271-285
12. Plotsky PM, Cunningham Jr. ET, Widmaier EP 1989 Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr Rev 10:437-458
13. Sawchenko PE 1989 Neuropeptides, the paraventricular nucleus, and the integration of hypothalamic neuroendocrine and autonomie function. In: Tache Y, Morley JE, Brown MR (eds) Neuropeptides and Stress. Springer-Verlag, New York, pp 73-92
14. Matta SG, Foster CA, Sharp BM 1993 Selective administration of nicotine into catecholaminergic regions of rat brainstem stimulates adrenocorticotropin secretion. Endocrinology 133:2935-2942
15. Sagar SM, Sharp FR, Curran T 1988 Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240:1328-1331
16. Sheng M, Greenberg ME 1990 The regulation of function of c-fos and other immediate early genes in the nervous system. Neuron 4:477-485
17. Morgan JI, Curran T 1991 Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci 14:421-451
18. Matta SG, Foster CA, Sharp BM 1993 Nicotine stimulates the expression of cFos protein in the parvocellular paraventricular nucleus and brainstem catecholaminergic regions. Endocrinology 132:2149-2156
19. Abood LG, Lowy K, Tometsko A, MacNeil M 1979 Evidence for a non-cholinergic site for nicotine's action in the brain: psychopharmacological, electrophysiological and receptor binding studies. Arch Int Pharmacodyn 237:213-229
20. Marks MJ, Burch JB, Collins AC 1983 Effects of chronic nicotine infusion on tolerance development and cholinergic receptors. J Pharmacol Exp Therap 226:806-816
21. Paxinos G, Watson C 1986 The Rat Brain in Sterotaxic Coordinates, ed 2. Academic Press, New York
22. Ceccatelli S, Cortes R, Hokfelt T 1991 Effect of reserpine and colchicine on neuropeptide mRNA levels in the rat hypothalamic paraventricular nucleus. Mol Brain Res 9:57-69
23. Berkenbosch F, Van Oers J, del Ray A, Tilders F, Besedovsky H 1987 Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238:524-526
24. McCoy JG, Matta SG, Sharp BM 1994 Prostaglandins mediate the ACTH response to interleukin-1 beta instilled into the hypothalamic median eminence. Neuroendocrinology 60:426-435
25. Watson RE, Wiegand SJ, Clough RW, Hoffman GE 1986 Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides 7:155-159
26. Cummings S, Sharp BM, Elde R 1988 Corticotropin-releasing factor in cerebellar afferent systems: a combined immunohistochemistry and retrograde transport study J Neurosci 8:543-554
27. Hokfelt T, Goldstein M, Fuxe K, Johansson O, Verhofstad A, Steinbusch H, Penke B, Vargas J 1980 Histochemical identification of adrenaline containing cells with special reference to neurons. In: Fuxe K, Goldstein M, Hokfelt B (eds) Central Adrenaline Neurons, Pergamon Press, New York, pp 19-48
28. Rivier C, Vale W 1983 Modulation of stress-induced ACTH release by corticotropin releasing factor, catecholamines and vasopressin. Nature 305:325
29. Szafarczyk A, Malaval F, Laurent A, Gibaud R, Assenmacher I 1987 Further evidence for a central stimulatory action of catecholamines on adrenocortotropin release in the rat. Endocrinology 121:883-892
30. Guillame V, Conte-Devolx B, Szafarczyk A, Malaval F, Pares-Herbute N, Grino M, Alonso G, Assenmacher I, Oliver C 1987 The Corticotropin-releasing factor release in rat hypophysial port blood is mediated by brain catecholamines. Neuroendocrinology 46:143-146
31. Plotsky PM 1987 Facilitation of immunoreactive Corticotropin-releasing factor secretion into the hypophyseal portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. Endocrinology 121:924-930
32. Swanson LW, Hartman BK 1975 The central adrenergic system: an immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-β-hydroxylase as a marker. J Comp Neurol 163:467-505
33. 3H]acteylcholine on catecholamine and serotonin axons in brain. J Neurochem 42:1495-1498
34. Yoshida K, Kato Y, Imura H 1980 Nicotine-induced release of noradrenalin from hypothalamic synaptosomes. Brain Res 182:361-368
35. Brazell MP, Mitchell SN, Gray JA 1991 Effect of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: a dose-response and antagonist study. Neuropharmacol 30:823-833